Mesothelioma Science News
San Pedro, CA - June 23,
2008
|
1.
|
Chemotherapy of malignant pleural mesothelioma: have we
made any progress?
Click here
|
|
|
|
|
2.
|
Multimodal therapy for malignant pleural mesothelioma
including extrapleural pneumonectomy
Click here
|
|
|
|
|
3.
|
Mesothelioma: a still current occupational cancer
Click here
|
|
|
|
|
4.
|
Asbestos burden predicts survival in pleural
mesothelioma
Click here
|
|
|
|
|
5.
|
Schedule-dependent synergistic effect of pemetrexed
combined with gemcitabine against malignant pleural
mesothelioma and non-small cell lung cancer cell lines
Click here
|
|
|
|
|
6.
|
Measles virus induces oncolysis of mesothelioma cells
and allows dendritic cells to cross-prime
tumor-specific CD8 response
Click here
|
|
|
|
|
7.
|
Mapping the risk of mesothelioma due to neighborhood
asbestos exposure
Click here
|
|
|
|
|
8.
|
Development of an exposure assessment method for
epidemiological studies of New York State personnel who
responded to the World Trade Center disaster
Click here
|
|
|
|
|
9.
|
Erlotinib plus bevacizumab in previously treated
patients with malignant pleural mesothelioma
Click here
|
|
|
|
|
10.
|
Cisplatin and vinorelbine first-line chemotherapy in
non-resectable malignant pleural mesothelioma
Click here
|
|
|
|
|
11.
|
Pemetrexed plus carboplatin in elderly patients with
malignant pleural mesothelioma: combined analysis of
two phase II trials
Click here
|
|
|
|
|